We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+7.95%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$24.3B
AUM Growth
+$1.52B
(+6.7%)
Cap. Flow
+$416M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
19.48%
Holding
1,977
New
232
Increased
535
Reduced
722
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$298M |
| 2 |
Spotify
SPOT
|
+$249M |
| 3 |
NVIDIA
NVDA
|
+$230M |
| 4 |
Cardinal Health
CAH
|
+$129M |
| 5 |
Vipshop
VIPS
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amdocs
DOX
|
+$125M |
| 2 |
Crane NXT
CXT
|
+$114M |
| 3 |
Deutsche Bank
DB
|
+$96M |
| 4 |
Qiagen
QGEN
|
+$92.3M |
| 5 |
Arista Networks
ANET
|
+$83.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Healthcare | 13.93% |
| 3 | Consumer Staples | 11.94% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Medpace
MEDP
$16.5B
| $18.2M | 0.07% |
75,767
-56,802
| -43% | -$11.8M |
|
|
VMW
227
DELISTED
VMware, Inc
VMW
| $18.2M | 0.07% |
126,550
-6,276
| -5% | -$814K |
|
228
Morgan Stanley
MS
$340B
| $17.9M | 0.07% |
209,601
+23,286
| +12% | +$1.99M |
|
229
Citigroup
C
$226B
| $17.8M | 0.07% |
385,936
+187,680
| +95% | +$8.79M |
|
230
United Therapeutics
UTHR
$23.1B
| $17.7M | 0.07% |
80,442
-79,008
| -50% | -$17.5M |
|
231
Lamb Weston
LW
$7.19B
| $17.5M | 0.07% |
152,202
-75,809
| -33% | -$8.46M |
|
|
MDC
232
DELISTED
M.D.C. Holdings, Inc.
MDC
| $17M | 0.07% |
364,361
+325,497
| +838% | +$13.6M |
|
233
Magna International
MGA
$18.8B
| $16.9M | 0.07% |
299,864
+95,200
| +47% | +$5.05M |
|
234
International Paper
IP
$22B
| $16.6M | 0.07% |
523,000
+99,278
| +23% | +$3.25M |
|
235
Centene
CNC
$32.5B
| $16.3M | 0.07% |
241,799
+222,268
| +1,138% | +$14.8M |
|
236
HCA Healthcare
HCA
$89.5B
| $15.7M | 0.06% |
51,668
-9,335
| -15% | -$2.6M |
|
237
Usana Health Sciences
USNA
$286M
| $15.5M | 0.06% |
246,753
-20,304
| -8% | -$1.29M |
|
238
Vulcan Materials
VMC
$36.9B
| $15.4M | 0.06% |
68,353
+67,669
| +9,893% | +$13M |
|
239
Kinross Gold
KGC
$32.8B
| $15.3M | 0.06% |
3,203,246
+2,687,246
| +521% | +$13.4M |
|
240
BioNTech
BNTX
$23.5B
| $15.2M | 0.06% |
141,166
+30,039
| +27% | +$3.38M |
|
241
BorgWarner
BWA
$13.9B
| $15M | 0.06% |
349,126
+10,384
| +3% | +$427K |
|
242
Synchrony
SYF
$25.6B
| $15M | 0.06% |
441,563
+294,779
| +201% | +$9M |
|
243
Zoom
ZM
$30.6B
| $14.9M | 0.06% |
220,173
+115,801
| +111% | +$7.74M |
|
244
Snap-on
SNA
$21.5B
| $14.8M | 0.06% |
51,435
-20,678
| -29% | -$5.35M |
|
|
HTT
245
High Templar Tech Ltd
HTT
$391M
| $14.8M | 0.06% |
7,384,051
-18,569
| -0.3% | -$26.8K |
|
246
AMN Healthcare
AMN
$1.4B
| $14.6M | 0.06% |
134,116
+12,264
| +10% | +$1.16M |
|
247
Powell Industries
POWL
$7.71B
| $14.6M | 0.06% |
722,820
+91,629
| +15% | +$1.59M |
|
|
DRD
248
DRDGold
DRD
$2.05B
| $14.6M | 0.06% |
1,374,059
+1,300,925
| +1,779% | +$14.8M |
|
249
Harley-Davidson
HOG
$2.71B
| $14.5M | 0.06% |
411,663
+100,821
| +32% | +$3.52M |
|
|
CYBR
250
DELISTED
CyberArk
CYBR
| $14.2M | 0.06% |
90,669
+74,067
| +446% | +$10.6M |
|
Similar funds
Acadian Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Acadian Asset Management held 1,977 positions worth $24.3B, up 6.7% from $22.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Acadian Asset Management's Q2 2023 filing shows 232 new, 535 increased, 722 reduced and 249 closed positions. Its largest new stake was Indivior Pharmaceuticals: 2,328,706 shares worth $54M. The largest sale was Amdocs, an estimated $125M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.
- Acadian Asset Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 2,328,706 shares worth $54M.
- Acadian Asset Management added most to Alphabet (Google) Class A in Q2 2023, an estimated $298M increase.
- Acadian Asset Management's biggest Q2 2023 reduction was Crane NXT, cutting an estimated $114M.
- Acadian Asset Management fully exited Amdocs in Q2 2023, selling an estimated $125M.
- Acadian Asset Management's ten largest holdings make up 19% of its $24.3B portfolio in Q2 2023.
- Acadian Asset Management opened 232 new positions and closed 249 in Q2 2023.
- Acadian Asset Management's portfolio value rose 6.7% quarter-over-quarter to $24.3B.
Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.